Systems biology approach highlights mechanistic differences between Crohn’s disease and ulcerative colitis
Abstract The molecular mechanisms of IBD have been the subject of intensive exploration. We, therefore, assembled the available information into a suite of causal biological network models, which offer comprehensive visualization of the processes underlying IBD. Scientific text was curated by using...
Guardado en:
Autores principales: | Pedro A. Ruiz Castro, Hasmik Yepiskoposyan, Sylvain Gubian, Florian Calvino-Martin, Ulrike Kogel, Kasper Renggli, Manuel C. Peitsch, Julia Hoeng, Marja Talikka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5020808525844ce6a5169f204e832fcc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
por: Petkau JM, et al.
Publicado: (2016) -
Selected Morphotic Parameters Differentiating Ulcerative Colitis from Crohn’s Disease
por: Kasperczuk Anna
Publicado: (2021) - Journal of Crohn's and colitis
-
Infliximab in ulcerative colitis
por: Avi Levin, et al.
Publicado: (2008) -
Biologics for Ulcerative Colitis: Status of the Art and General Considerations
por: Giovanni Clemente Actis
Publicado: (2017)